MedTrace Logo

BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects

NCT01977859 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2018-02-14

No results posted yet for this study

Summary

The purpose of this study is to collect data to help researchers better understand the various causes of obesity, which may lead to the development of new obesity treatment options.

Conditions

Interventions

DRUG

Nesiritide

DRUG

Saline

Sponsors & Collaborators

  • Sanford-Burnham Medical Research Institute

    collaborator OTHER

  • AdventHealth Translational Research Institute

    lead OTHER

Principal Investigators

  • Richard E. Pratley, MD · AdventHealth

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-02-15
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01977859 on ClinicalTrials.gov